George P Kim Selected Research

George P Kim Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 04/2007
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2007
8	Adenocarcinoma 01/2022 - 07/2008
7	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2005
4	Hepatocellular Carcinoma (Hepatoma) 10/2012 - 05/2007
3	Carcinoma (Carcinomatosis) 02/2012 - 07/2008
2	Fatigue 01/2018 - 08/2012
2	Nausea 01/2018 - 06/2009
2	Cholangiocarcinoma 05/2012 - 05/2007
2	Microsatellite Instability 06/2011 - 03/2007
1	Constipation 01/2018
1	Back Pain (Backache) 01/2018
1	Hyperglycemia 03/2016
1	Ovarian Neoplasms (Ovarian Cancer) 03/2016
1	Hypophosphatemia 03/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2015
1	Leukemia 04/2014
1	Liver Diseases (Liver Disease) 11/2013
1	Anorexia 08/2012
1	Hypertension (High Blood Pressure) 08/2012
1	Obesity 02/2012
1	Colonic Neoplasms (Colon Cancer) 06/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Vomiting 06/2009
1	Neutropenia 06/2009
1	Paresthesia (Dysesthesia) 06/2009
1	Febrile Neutropenia 06/2009
1	Diarrhea 06/2009
1	Hypersensitivity (Allergy) 06/2008

Drug/Important Bio-Agent (IBA)

9	Gemcitabine FDA Link 01/2022 - 09/2012
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 11/2005
5	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 04/2007
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2005
3	Panitumumab (Vectibix)FDA Link 01/2022 - 06/2008
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2021 - 06/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 07/2010
3	Leucovorin (Folinic Acid)FDA Link 05/2017 - 04/2007
3	Bevacizumab (Avastin)FDA Link 04/2014 - 04/2007
3	Cetuximab (Erbitux)FDA Link 09/2012 - 04/2007
2	Docetaxel (Taxotere)FDA Link 01/2021 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 01/2018 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 06/2011
2	Cisplatin (Platino)FDA LinkGeneric 07/2015 - 08/2014
2	Alanine Transaminase (SGPT)IBA 11/2013 - 08/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 07/2010
1	Capecitabine (Xeloda)FDA Link 01/2021
1	HhAntag691IBA 01/2020
1	ontuxizumabIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 05/2017
1	folfirinoxIBA 05/2017
1	MesothelinIBA 03/2016
1	monomethyl auristatin EIBA 03/2016
1	PlatinumIBA 03/2016
1	Immunoconjugates (Immunoconjugate)IBA 03/2016
1	Antimitotic AgentsIBA 03/2016
1	tanespimycin (17AAG)IBA 08/2015
1	Cytotoxins (Cytolysins)IBA 08/2015
1	Carcinoembryonic AntigenIBA 08/2015
1	Carboplatin (JM8)FDA LinkGeneric 07/2015
1	Everolimus FDA Link 08/2014
1	Dihydrotachysterol (AT 10)IBA 07/2014
1	BilirubinIBA 11/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2013
1	ixabepilone (BMS 247550)FDA Link 09/2012
1	cediranib (AZD2171)IBA 08/2012
1	Bortezomib (Velcade)FDA Link 02/2012
1	Tyrosine Kinase InhibitorsIBA 07/2010
1	AntibodiesIBA 06/2008
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2007
1	Folic Acid AntagonistsIBA 07/2007
1	Pemetrexed (MTA)FDA Link 07/2007
1	pyrimidineIBA 07/2007
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 07/2007
1	purineIBA 07/2007
1	Biological ProductsIBA 04/2007

Therapy/Procedure

9	Therapeutics 01/2021 - 05/2007
8	Drug Therapy (Chemotherapy) 01/2022 - 07/2007
4	Adjuvant Chemotherapy 08/2015 - 03/2007
3	Liver Transplantation 05/2012 - 05/2007
2	Neoadjuvant Therapy 01/2021 - 05/2012
2	Combination Drug Therapy (Combination Chemotherapy) 04/2014 - 07/2010
1	Chemoradiotherapy 01/2022
1	Drug Tapering 02/2021
1	Induction Chemotherapy 01/2021
1	Retreatment 03/2016
1	Microspheres (Microsphere) 11/2013
1	Radiotherapy 07/2008
1	Adjuvant Radiotherapy 07/2008